Roberta Santos Azevedo, MD
Hematology & Oncology Physician · Houston, TX
Roberta Santos Azevedo, MD is a hematology & oncology physician with a practice address in Houston, Texas, and NPI 1386483949, issued on May 23, 2024. Check the license (Texas BP10087614, as entered in NPPES) on the Texas Medical Board; the Medicare figures below come from public CMS files.
- Name
- Roberta Santos Azevedo
- Credential
- MD
- Primary taxonomy
- Hematology & Oncology Physician 207RH0003X
- License number
- BP10087614 TX
Self-reported in NPPES; status is on the state search - Practice location
- 1515 Holcombe Blvd, Houston, TX 77030
- Phone
- (713) 745-5076
- Enumerated
- May 23, 2024
- Record last updated
- May 23, 2024
- Entity
- Type 1 · individual
Also registered at 1515 Holcombe Blvd
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Ashley Aaroe, MDNeurology Physician1902295793
- Linda Abad, PA-CPhysician Assistant1063928240
- Cynthia Abarado, RN, GNPGerontology Nurse Practitioner1851471049
- Hussein Abbas, MD, PHDInternal Medicine Physician1609220532
- James Abbruzzese, M.D.Medical Oncology Physician1134233224
- Karim Abdeldaem, MDEmergency Medicine Physician1558056200
Verify Roberta Santos Azevedo in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersTexas Medical Board
Search for license BP10087614Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
Industry payments in 2024: $28.05
1 payment: food and beverage; the largest payer was GlaxoSmithKline, LLC. The 8,560 providers of this specialty with any payment received $7,481.41 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Hematology & Oncology Physician providers in Texas
There are 922 hematology & oncology physician records in Texas.
Other hematology & oncology physician records in Texas
- Kanza Abbas, M.D.Houston, TX1396065934
- Elham Abbasi-Hafshejani, M.D.The Woodlands, TX1306856513
- Raghad Abdul-Karim, MDMcAllen, TX1114207172
- Seyed Abedi, M.D.,PH.D.Cedar Park, TX1033567409
- Muhammad Abid, M.D.Lubbock, TX1639480437
- Ambrose Aboud, MDEl Paso, TX1407843873
- Hesham Abowali, MDGalveston, TX1447806955
- Joel Abramowitz, M.D., PHDHouston, TX1447220413
- Hussna Abunafeesa, M.DDallas, TX1902338726
- Prashanth Adapala, M.D.Marble Falls, TX1740484336
Common questions
What is Roberta Santos Azevedo, MD's NPI number?
Roberta Santos Azevedo, MD's National Provider Identifier (NPI) is 1386483949, issued on May 23, 2024. An NPI identifies a provider in billing; it is not a license.
Where is Roberta Santos Azevedo, MD located?
The NPPES record lists a practice address at 1515 Holcombe Blvd, Houston, TX, 77030. Phone: (713) 745-5076. Providers update this record themselves, so call before visiting.
How can I verify Roberta Santos Azevedo, MD's license?
NPPES lists Texas license number BP10087614, as entered by the provider. Search the Texas Medical Board at https://profile.tmb.state.tx.us/Search.aspx. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.